Chimeric Antigen Receptor (CAR) T-Cell Products for Pediatric Cancers: Why Alternative Development Paths Are Needed
Claudia Rössig, Andrew D.J. Pearson, Gilles Vassal, Nicole Scobie, Nick Bird, P. Blanc, Josef Vormoor, Friso Calkoen, Franco Locatelli, Francesca Del Bufalo, Susana Rives, Elad Jacoby, Adriana Balduzzi, Jean‐Pierre Bourquin, André Baruchel
Topics & Concepts
Chimeric antigen receptorMedicineAntigenReceptorImmunologyCancer researchImmunotherapyImmune systemInternal medicineCAR-T cell therapy research